Navigation Links
One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs
Date:6/18/2013

BURLINGTON, Mass., June 18, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, over the past 12 months, 25 percent of surveyed physicians from the EU5 (France, Germany, Italy, Spain and the United Kingdom) have been required to change the antiretroviral (ARV) prescription for some or most of their HIV patients, primarily to reduce costs. Additionally, more than 40 percent of respondents report that changing prescriptions is strongly encouraged or that they give preference to lower priced ARVs. These findings reflect the tightening healthcare budgets throughout the EU5 as over 20 percent of surveyed physicians indicate that their budgets for ARV treatments have decreased in the last year.  

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO )

The new European Physician and Payer Forum report entitled The Approaching Cliff: How Will the Availability of Generic Antiretrovirals Impact the EU5 Prescribing and Reimbursement Landscape for Current and Emerging Brands in HIV? finds that surveyed physicians currently prescribe once-daily, single tablet regimens (STRs), such as Gilead/Bristol-Myers Squibb's Atripla and Gilead/Janssen's Eviplera to more than 40 percent of their HIV patients. Furthermore, despite cost containment efforts from payers and the upcoming generic availability of some STR components, the convenience of one pill dosed once daily, the recent launch of Gilead's integrase inhibitor-based STR Stribild, and the anticipated availability of ViiV's 572-Trii will drive respondents to expand use of STRs to half of the
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rising Drug Resistance is Driving Early-Line Use of Powerful Antibiotics Such as Carbapenems for Gram-Negative Infections, According to Surveyed EU5 Physicians
2. For Second- and Subsequent-Line Metastatic Castrate-Resistant Prostate Cancer, Surveyed Oncologists Indicate that Improved Symptom Control and Quality of Life is one of the Greatest Unmet Needs
3. For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs
4. The Majority of Surveyed Gastroenterologists in the EU5 Identify Remicade as Their Most Preferred Biologic for the Treatment of Ulcerative Colitis
5. For Treating Clostridium difficile Infections, Surveyed Infectious Disease Specialists Agree That Effect on Recurrence Rate is One of the Drug Attributes that Most Influences Their Prescribing Decisions
6. Surveyed U.S. Pulmonologists Expect to Treat Nearly 50 Percent of Their Severe, Refractory Asthma Patients With a Biologic or Biosimilar Version of Xolair By the End of 2018
7. Surveyed U.S. Neurologists Would Prescribe Biogen Idecs Tecfidera to 20 Percent of Their Patients with Relapsing-Remitting Multiple Sclerosis (RR-MS)
8. Surveyed U.S. Physicians Indicate That Xarelto and Apixaban Will Benefit From the Lack of Use of a Fast-Acting Injectable Anticoagulant in the Treatment and Secondary Prophylaxis of Deep Vein Thrombosis/Pulmonary Embolism
9. Despite the Recent Availability of Xtandi, Zytiga Continues to Dominate the Second-Line Metastatic Castrate-Resistant Prostate Cancer Setting, According to Surveyed U.S. Oncologists and Urologists
10. Surveyed U.S. and European Neurologists Agree that a Therapys Effect on Physical Disability is the Most Important Attribute Influencing Prescribing Decisions in Secondary-Progressive Multiple Sclerosis
11. According to Surveyed Oncologists in the EU5, Zytiga Has Heavily Penetrated Second-Line Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) and is Displacing Jevtana to Later-Line mCRPC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Spanien, September 23, 2014 ... dass sich Fernzugriffe auf eTMF im Jahr ... ermöglicht den Sponsoren von klinischen Versuchsreihen, die ... und Vollständigkeit von Stammdateien mit Informationen über ... zu erfüllen     Die bisher ...
(Date:9/22/2014)... 22, 2014 Levi & Korsinsky is investigating ... "the Company") (NasdaqGS: SIAL ) for possible ... law in connection with the sale of the Company ... to learn more about the investigation: http://zlkdocs.com/SIAL-Info-Request-Form_ma-2199 , ... to you. Under the terms of the ...
(Date:9/22/2014)... , Sept. 22, 2014 Avanir Pharmaceuticals, ... it is offering to sell $200 million of its ... Deutsche Bank Securities and BofA Merrill Lynch are acting ... grant the underwriters a 30-day option to purchase additional ... to be sold in the offering are being sold ...
Breaking Medicine Technology:Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 2Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 3Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 4Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 5SIGMA-ALDRICH INVESTOR ALERT: Levi & Korsinsky, LLP Investigates the Board of Directors of Sigma-Aldrich Corporation In Connection with the Sale of the Company to Merck -- SIAL 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3
... S.C., Sept. 9 At approximately 3:21,PM ... Chairman and Founder of,CureHIV.us, agreed to act ... Global,Humanceuticals, Inc,s., new extremely effective, safe and ... non-government, U.S.,and foreign institutions, organizations, and corporations, ...
... Effective Antibiotics Against ,Superbugs, BOSTON, Sept. 6 ... may have discovered the path,toward developing better drugs ... resistance to common antibiotics. The,researchers have discovered a ... opens to door to new avenues of research., ...
Cached Medicine Technology:Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug 2Boston University Biomedical Engineers Find Chink in Bacteria's Armor 2Boston University Biomedical Engineers Find Chink in Bacteria's Armor 3
(Date:9/23/2014)... September 23, 2014 Steven Winter Associates, ... firm’s recent projects in the State of Connecticut – ... Gateway at 570 – were honored by the Connecticut ... Awards held on September 18, 2014 at Stepping Stones ... High School, Bridgeport , Recipient of the Institutional Award ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 ... of 3.7 out of 5, indicating moderate buyer ... portable and range from basic household carbon monoxide ... gas concentrations in parts per million. Buyers benefit ... choice of many suppliers, especially amongst distributors,” according ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 Ale Gicqueau, ... presenting on Advanced Data Visualization for Clinical Trials at ... SDE in San Francisco on Friday, September 26, 2014. ... by volunteers. Since its inception, PhUSE has expanded from ... to a global platform for the discussion of topics ...
(Date:9/23/2014)... With the emergence of CVS Health and its ... retail chains are transforming the healthcare landscape to provide ... shoppers. In this capacity, Inside Pharmacy™ is a forum ... share their knowledge on patient care, achieve professional success, ... with other colleagues inside the pharmacy. , This latest ...
(Date:9/23/2014)... September 23, 2014 Published by Nationwide Lifts, ... issues to take charge of their mobility in a new ... positively impactful. Stair lifts are that equipment and ... “Being in the elevator business, I’ve seen so ... themselves or a loved one with mobility issues,” said Andy ...
Breaking Medicine News(10 mins):Health News:Steven Winter Associates’ Projects Receive 2014 Green Building Awards 2Health News:Steven Winter Associates’ Projects Receive 2014 Green Building Awards 3Health News:Gas Detectors Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Gas Detectors Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Clinovo Sponsors and Presents at Pharmaceutical Users Software Exchange (PhUSE) SDE in San Francisco 2Health News:Retail Pharmacies at the Forefront of Primary Care Innovation 2Health News:Nationwide Lifts, America’s Leader in Home Elevators, Is Proud to Announce the Release of Its First Book, “Stair Lifts: Move Up, Not Out!” 2
... when therapy goes to more than just severe cases, ... Pregnant women who receive treatment for the mildest forms ... self-monitoring of blood glucose levels and possibly insulin therapy ... or develop preeclampsia or high blood pressure during pregnancy, ...
... ... Kraft , ... September 30, 2009 -- The Boston biotechnology industry will get an early look at biotech,s ... 27, 2009 at Harvard Medical School. , , ,At the one-day event, recently funded companies ...
... children don,t see their family dentist until they are well ... both dental and medical professionals. , That,s one of the ... conducted on behalf of Delta Dental Plans Association, the nation,s ... gain greater knowledge about the state of children,s oral health. ...
... Incorporated (NYSE: HR ) announced it has entered into ... previous $400 million facility. The new facility includes 16 ... priced at 2.80% over LIBOR, with a 0.40% facility fee, ... loans of this nature. , Healthcare Realty Trust ...
... TOLEDO, Ohio, Sept. 30 Heartland Information Services, a ... Brett S. Himes to President and Chief Executive Officer. ... will assume the President and CEO position immediately. , ... C. Cirino, who has accepted a new position with ...
... Walter and Eliza Hall Institute researchers have put an ... a molecular messenger called Fas ligand is responsible for ... Apoptosis is an important process in human biology ... bodies, protecting us against cancer development and diseases where ...
Cached Medicine News:Health News:Study Urges Treatment for Even Mild Gestational Diabetes 2Health News:Study Urges Treatment for Even Mild Gestational Diabetes 3Health News:Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery 2Health News:Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery 3Health News:Delayed First Visit to Dentist Can Affect Children's Lifelong Oral Health 2Health News:Healthcare Realty Trust Announces New $550 Million Unsecured Revolving Credit Facility 2Health News:Heartland Information Services Appoints New Chief Executive Officer 2Health News:Research puts a 'Fas' to the cause of programmed cell death 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: